BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

857 related articles for article (PubMed ID: 28912154)

  • 61. Cyclin-dependent kinase 5--a neuronal killer?
    Guo Q
    Sci Aging Knowledge Environ; 2003 Dec; 2003(50):pe36. PubMed ID: 14681576
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Roscovitine, a Cyclin-Dependent Kinase-5 Inhibitor, Decreases Phosphorylated Tau Formation and Death of Retinal Ganglion Cells of Rats after Optic Nerve Crush.
    Hirokawa T; Horie T; Fukiyama Y; Mimura M; Takai S; Kida T; Oku H
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360858
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
    Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
    Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Amelioration of Tau pathology and memory deficits by targeting 5-HT7 receptor.
    Labus J; Röhrs KF; Ackmann J; Varbanov H; Müller FE; Jia S; Jahreis K; Vollbrecht AL; Butzlaff M; Schill Y; Guseva D; Böhm K; Kaushik R; Bijata M; Marin P; Chaumont-Dubel S; Zeug A; Dityatev A; Ponimaskin E
    Prog Neurobiol; 2021 Feb; 197():101900. PubMed ID: 32841723
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
    Liu M; Wang L; Gao J; Dong Q; Perry G; Ma X; Wang X
    J Alzheimers Dis; 2019; 69(4):1077-1087. PubMed ID: 31156179
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.
    Shukla V; Skuntz S; Pant HC
    Arch Med Res; 2012 Nov; 43(8):655-62. PubMed ID: 23142263
    [TBL] [Abstract][Full Text] [Related]  

  • 67. The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation.
    Plattner F; Angelo M; Giese KP
    J Biol Chem; 2006 Sep; 281(35):25457-65. PubMed ID: 16803897
    [TBL] [Abstract][Full Text] [Related]  

  • 68. A Cdk5 inhibitory peptide reduces tau hyperphosphorylation and apoptosis in neurons.
    Zheng YL; Kesavapany S; Gravell M; Hamilton RS; Schubert M; Amin N; Albers W; Grant P; Pant HC
    EMBO J; 2005 Jan; 24(1):209-20. PubMed ID: 15592431
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Blocking Site-Specific Cleavage of Human Tau Delays Progression of Disease-Related Phenotypes in Genetically Matched Tau-Transgenic Mice Modeling Frontotemporal Dementia.
    Steuer EL; Kemper LJ; Hlynialuk CJW; Leinonen-Wright K; Montonye ML; Lapcinski IP; Forster CL; Ashe KH; Liu P
    J Neurosci; 2022 Jun; 42(23):4737-4754. PubMed ID: 35508385
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Neurotrophin receptor p75 mediates amyloid β-induced tau pathology.
    Shen LL; Li WW; Xu YL; Gao SH; Xu MY; Bu XL; Liu YH; Wang J; Zhu J; Zeng F; Yao XQ; Gao CY; Xu ZQ; Zhou XF; Wang YJ
    Neurobiol Dis; 2019 Dec; 132():104567. PubMed ID: 31394202
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Axonopathy, tau abnormalities, and dyskinesia, but no neurofibrillary tangles in p25-transgenic mice.
    Bian F; Nath R; Sobocinski G; Booher RN; Lipinski WJ; Callahan MJ; Pack A; Wang KK; Walker LC
    J Comp Neurol; 2002 May; 446(3):257-66. PubMed ID: 11932941
    [TBL] [Abstract][Full Text] [Related]  

  • 72. P25/CDK5-mediated Tau Hyperphosphorylation in Both Ipsilateral and Contralateral Cerebra Contributes to Cognitive Deficits in Post-stroke Mice.
    Yu J; Zhao Y; Gong XK; Liang Z; Zhao YN; Li X; Chen YJ; Yang YH; Wu MJ; Wang XC; Shu XJ; Bao J
    Curr Med Sci; 2023 Dec; 43(6):1084-1095. PubMed ID: 37924385
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Involvement of cyclin dependent kinase5 activator p25 on tau phosphorylation in mouse brain.
    Takashima A; Murayama M; Yasutake K; Takahashi H; Yokoyama M; Ishiguro K
    Neurosci Lett; 2001 Jun; 306(1-2):37-40. PubMed ID: 11403952
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
    van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
    Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Deregulation of cdk5 in Hippocampal sclerosis.
    Sen A; Thom M; Martinian L; Jacobs T; Nikolic M; Sisodiya SM
    J Neuropathol Exp Neurol; 2006 Jan; 65(1):55-66. PubMed ID: 16410749
    [TBL] [Abstract][Full Text] [Related]  

  • 76. p39 Is Responsible for Increasing Cdk5 Activity during Postnatal Neuron Differentiation and Governs Neuronal Network Formation and Epileptic Responses.
    Li W; Allen ME; Rui Y; Ku L; Liu G; Bankston AN; Zheng JQ; Feng Y
    J Neurosci; 2016 Nov; 36(44):11283-11294. PubMed ID: 27807169
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Vectored Intracerebral Immunization with the Anti-Tau Monoclonal Antibody PHF1 Markedly Reduces Tau Pathology in Mutant Tau Transgenic Mice.
    Liu W; Zhao L; Blackman B; Parmar M; Wong MY; Woo T; Yu F; Chiuchiolo MJ; Sondhi D; Kaminsky SM; Crystal RG; Paul SM
    J Neurosci; 2016 Dec; 36(49):12425-12435. PubMed ID: 27927959
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Generation of a human induced pluripotent stem cell-based model for tauopathies combining three microtubule-associated protein TAU mutations which displays several phenotypes linked to neurodegeneration.
    García-León JA; Cabrera-Socorro A; Eggermont K; Swijsen A; Terryn J; Fazal R; Nami F; Ordovás L; Quiles A; Lluis F; Serneels L; Wierda K; Sierksma A; Kreir M; Pestana F; Van Damme P; De Strooper B; Thorrez L; Ebneth A; Verfaillie CM
    Alzheimers Dement; 2018 Oct; 14(10):1261-1280. PubMed ID: 30036493
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The levels of cdk5 and p35 proteins and tau phosphorylation are reduced during neuronal apoptosis.
    Kerokoski P; Suuronen T; Salminen A; Soininen H; Pirttilä T
    Biochem Biophys Res Commun; 2001 Feb; 280(4):998-1002. PubMed ID: 11162625
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Synapse loss and microglial activation precede tangles in a P301S tauopathy mouse model.
    Yoshiyama Y; Higuchi M; Zhang B; Huang SM; Iwata N; Saido TC; Maeda J; Suhara T; Trojanowski JQ; Lee VM
    Neuron; 2007 Feb; 53(3):337-51. PubMed ID: 17270732
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.